GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach

Joint Authors

Petignat, Patrick
Cohen, Marie
Delie, Florence

Source

Journal of Oncology

Issue

Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-5, 5 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2012-03-18

Country of Publication

Egypt

No. of Pages

5

Main Subjects

Diseases
Medicine

Abstract EN

Glucose-regulated protein of 78 kD (GRP78) is a chaperone protein mainly located in the endoplasmic reticulum (ER).

This protein is normally present at low levels in adult cells but its expression is triggered by ER stress including glucose deprivation and hypoxia.

In tumor cells, it is overexpressed with fraction of protein found at the cell surface.

This paper presents the physiology of GRP78 in the context of ovarian cancer and its potential use as drug delivery systems targeting ovarian cancer cell.

American Psychological Association (APA)

Delie, Florence& Petignat, Patrick& Cohen, Marie. 2012. GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach. Journal of Oncology،Vol. 2012, no. 2012, pp.1-5.
https://search.emarefa.net/detail/BIM-473912

Modern Language Association (MLA)

Delie, Florence…[et al.]. GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach. Journal of Oncology No. 2012 (2012), pp.1-5.
https://search.emarefa.net/detail/BIM-473912

American Medical Association (AMA)

Delie, Florence& Petignat, Patrick& Cohen, Marie. GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach. Journal of Oncology. 2012. Vol. 2012, no. 2012, pp.1-5.
https://search.emarefa.net/detail/BIM-473912

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-473912